Tumour | |
---|---|
Number of patients, n | 120 |
Age, median (range) | 60 (29–83) |
Gender, n (%) | |
Male | 73 (61) |
Female | 47 (39) |
Histological subtype, n (%) | |
Clear cell RCC | 30 (25) |
Papillary RCC | 30 (25) |
Chromophobe RCC | 30 (25) |
Oncocytoma | 30 (25) |
Pathological stage, n (%) | |
Stage I | 47 (39) |
Stage II | 19 (16) |
Stage III | 21 (17.5) |
Stage IV | 3 (2.5) |
n.a. (oncocytoma) | 30 (25) |
Nuclear grade, n (%) | |
Grade 1 | 3 (2.5) |
Grade 2 | 23 (19) |
Grade 3 | 29 (24.5) |
Grade 4 | 5 (4) |
n.a. (chRCC and oncocytoma) | 60 (50) |
Metastasis during follow-up | |
Clear cell RCC | 9 (7.5) |
Papillary RCC | 7 (5.8) |
Chromophobe RCC | 1 (0.8) |